| Application no. and date | 18190333.7 (espacenet) (Federated) (European Patent Register), 20150112 | | Patent/reg. no. and date | DK/EP 3466955, 20201216 | | Publication date | 20190410 | | Priority no. and date | IN 158CH2014, 20140113, IN 3000CH2014, 20140620 | | EP pub. no. and date |
EP 3466955 20190410 | | Effective date | | | Applicant/owner | Aurigene Oncology Limited, 39-40 KIADB Industrial Area
Electronics City Phase-II
Hosur Road
Bangalore, Karnataka 560100, IN | | Applicant ref. no. | V2101-012-DK | | Inventor | SAMAJDAR, Susanta, Flat R801
H. M Tambourine
Jaraganahalli
J.P. Nagar 6th
Phase
Bangalore 560078, IN,
GUMMADI, Venkateshwar, Rao, Balaji Nilayam 62 1st main
Veerabhadraswamylayout
Doddanagamangala
Electronic City
Bangalore 560100, IN | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/437 (2006.01) , A61P 35/00 (2006.01) , C07D 498/04 (2006.01) , C07D 513/04 (2006.01) , C07D 519/00 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF OXAZOL[4,5-B]PYRIDIN OG THIAZOL[4,5-B]PYRIDINDERIVATER SOM IRAK4-HÆMMERE TIL BEHANDLING AF CANCER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
